Therapeutic Focus - Oncology | Takeda Pharmaceuticals

Our leadership in oncology extends nearly three decades and reflects a commitment to advancing treatment options that enhance and extend the lives of people living with a range of cancers.

We're working to ensure patients everywhere can access and benefit from our portfolio of approved medicines, while continuing to develop new treatment options for patients with unmet needs. Our pipeline focuses on thoracic, gastrointestinal and hematologic cancers and our core modalities include antibody-drug conjugates (ADCs), complex biologics, small molecules and gamma delta T cell therapies.

Through collaboration with partners who share our aspiration to cure cancer, we aim to advance innovation to rapidly meet the needs of the cancer community. For more information, visit www.takedaoncology.com.